How to Buy Niagen Bioscience Stock
Niagen Bioscience Inc
Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide. .
Niagen Bioscience stock last closed at $6.76, up 3.36% from the previous day, and has increased 70.28% in one year. It has overperformed other stocks in the Biotechnology industry by 1.49 percentage points. Niagen Bioscience stock is currently +193.28% from its 52-week low of $2.31, and -26.36% from its 52-week high of $9.18.
There are currently 77.75M shares of NAGE outstanding. The market value of NAGE is $525.59M. In the past 24 hours, 703,910 NAGE shares were traded.
How to Buy Niagen Bioscience Stock
Wondering how to invest in Niagen Bioscience stock? Here's how.
- Choose where to buy Niagen Bioscience stock: You need to pick an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you determine where to buy Niagen Bioscience stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Choose your method of payment and add your information.
- Analyze Niagen Bioscience stock: The Niagen Bioscience ticker symbol is NAGE. Is Niagen Bioscience stock a good investment? Should you buy shares of NAGE? How do NAGE's underlying business fundamentals look? Do top analysts think Niagen Bioscience is a good buy? Why has NAGE's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if NAGE is a good stock to buy).
- Execute your NAGE purchase: Decide if you will purchase NAGE shares at the current market price or use a limit order to buy NAGE shares at a particular price.
- Get the latest news on your NAGE position: Create a watchlist to watch your investment in Niagen Bioscience stock.
Step 1: Choose where to buy Niagen Bioscience stock
You need a brokerage account to access the NASDAQ market and buy NAGE stock.
Our recommended brokerage: eToro
Based on our research, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected your brokerage, the next step is to fill out some personal details so you are able to invest in NAGE stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to create a new trading account.
- Send your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have finished signing up on the best stock broker app, you can securely and quickly fund your account:
Watch the walkthrough below if you need help depositing funds into your investment account.
Step 4: Analyze Niagen Bioscience stock
Once you have chosen the best place to buy Niagen Bioscience stock, it's absolutely critical to research their stock prior to buying, so you truly wrap your head around the risk and upside.
Niagen Bioscience stock quick numbers
Niagen Bioscience Overview
WallStreetZen was built to help part-time investors do more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on NAGE's stock page.
Is NAGE stock properly valued?
Investors use many financial metrics, analyses, models, and charts to gauge NAGE's true value.
Using relative valuations ratios:
- NAGE may be undervalued based on its P/E ratio of 61.45x, relative to Biotechnology industry P/E ratio of -177.72x
- NAGE could be overvalued based on its P/B ratio of 11.4x, relative to Biotechnology industry P/B ratio of 4.05x
- NAGE could be overvalued based on its PEG ratio of 1.9x
You can access additional valuation analysis on NAGE's stock here.
NAGE Financial Summary
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the NAGE balance sheet.
- NAGE profit margin has gone up from -5.9% to 8.6% in the past year.
- Total NAGE debt is lower than 5 years ago, relative to shareholder equity.
- NAGE's operating cash flow of $12.11M allows it to safely service it's debt of $2.65M.
- There are more short-term assets than long-term liabilities on the NAGE balance sheet.
- NAGE earnings of $8.86M is not enough to cover its interest payments.
Negative Financial Indicators:
- NAGE has a relatively high debt to equity ratio of 0.48.
Do Wall Street analysts think it's a good time to buy NAGE stock
Out of 3 Wall Street analysts who research NAGE, the consensus analyst rating on NAGE is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Niagen Bioscience stock forecast page.
NAGE Trading Indicators
NAGE Performance Numbers
Last year, NAGE revenue was $99.60M. Over the past five year, NAGE's revenue has gone up by 16.56% per year. This was slower than the Biotechnology industry average of 44.43%.
You can analyze NAGE's earnings and revenue performance here.
Latest Insiders Trades at NAGE
In the last year, executives and large shareholders at NAGE have bought more shares than they have sold.
Robert N. Fried, Chief Executive Officer of NAGE, was the latest NAGE insider to buy. They bought $220,001.10 worth of NAGE shares on Apr 9, 2025.
Research more about who owns NAGE stock here.
Does NAGE provide a stable income stream?
No, Niagen Bioscience doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your NAGE purchase
You have two primary options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly sufficient. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a specific dollar amount limit, use a limit order.
Press the Open Trade button and your broker will execute the order.
If you need additional info about investing in stocks on eToro, watch the helpful video below:
Step 6: Get the latest news on your NAGE position
Now that you own some shares in NAGE, you'll want to keep up with your new shares.
Make a watchlist to get notified of important updates regarding your NAGE stock.
NAGE Feed
How to Buy Stock in Niagen Bioscience
To reiterate, here are the 6 steps to buy stock in Niagen Bioscience:
- Choose where to buy Niagen Bioscience stock
- Open a brokerage account
- Deposit money your investment account
- Analyze Niagen Bioscience stock
- Execute your NAGE purchase
- Get the latest news on your NAGE position
If you require a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to watch your new investment in Niagen Bioscience, create a watchlist today.
Other Articles You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.